FDA Inspection 887560 — RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank

RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank — FEI 2270850

The FDA completed an inspection of RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank on July 15, 2014 in Newark, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 15, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newark, NJ (United States)